Guardant Health (NASDAQ: GH) sets September 2025 Investor Day with executive presentations

Rhea-AI Filing Summary

Guardant Health, Inc. announced that it will host an Investor Day on September 24, 2025, beginning at 9:00 a.m. Eastern time in New York City. The event will feature presentations by co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz, along with other executive leaders.

The company plans to highlight its operations and provide updates on key strategic priorities and financial outlook. A live and archived webcast of the presentation will be available through the Investors section of Guardant Health’s website, allowing both in-person and remote participants to follow the event.

8-K Event Classification

Item 7.01 — Regulation FD Disclosure

1 item

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0001576280false00015762802025-09-242025-09-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 24, 2025

GUARDANT HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-38683

45-4139254

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

3100 Hanover Street

Palo Alto, California 94304

(Address of principal executive offices) (Zip Code)

855-698-8887

(Registrant’s telephone number, include area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.00001 par value per share			GH			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 7.01 Regulation FD Disclosure.

Guardant Health, Inc. (the “Company”) will host an Investor Day on September 24, 2025 beginning at 9:00 a.m. Eastern time in New York City. The presentation will include remarks from Helmy Eltoukhy and AmirAli Talasaz, co-Chief Executive Officers, and other members of the executive management team, to highlight the Company’s operations and to provide updates to the Company’s key strategic priorities and financial outlook.

All interested parties may access the live and archived webcast of the presentation on the “Investors” section of the Company’s website at: www.guardanthealth.com.

The information in this Current Report on Form 8-K is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						GUARDANT HEALTH, INC.
Date:			September 24, 2025			By:			/s/ John G. Saia
									John G. Saia
									Chief Legal Officer and Corporate Secretary

FAQ

What did Guardant Health (GH) disclose in this 8-K filing?

Guardant Health disclosed that it will host an Investor Day on September 24, 2025 in New York City. The event will feature management presentations on operations, strategic priorities, and financial outlook, with a live and archived webcast available via the company’s Investors website.

When and where is Guardant Health’s 2025 Investor Day taking place?

Guardant Health’s Investor Day is scheduled for September 24, 2025, starting at 9:00 a.m. Eastern time in New York City. The company will also provide a live and archived webcast through the Investors section of its website for remote participants.

Who will present at Guardant Health (GH) Investor Day 2025?

The Investor Day presentation will include remarks from co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz. Other members of Guardant Health’s executive management team will also speak, covering company operations, strategic priorities, and the financial outlook.

How can investors access Guardant Health’s Investor Day webcast?

Investors can access both the live and archived webcast of Guardant Health’s Investor Day through the Investors section of the company’s website at www.guardanthealth.com. This enables interested parties who cannot attend in person to follow management’s presentations and updates.

Does this Guardant Health 8-K include filed financial information?

No, the 8-K states that the Investor Day information is being furnished under Regulation FD and is not deemed filed under Section 18 of the Exchange Act. It focuses on announcing the event and planned topics, not providing detailed financial statements.

What topics will Guardant Health cover at its 2025 Investor Day?

Guardant Health plans to highlight its overall operations and provide updates on key strategic priorities and financial outlook. Presentations by the co-CEOs and other executives aim to give investors a clearer view of the company’s direction and business focus.